NicOx SA (COX.PA) Attends 2013 Congress of the French Society of Ophthalmology (SFO) in Paris
5/3/2013 10:51:44 AM
More...
|
Vicente Anido, Jr. Nominated for Election to NicOx SA (COX.PA)'s Board of Directors
4/26/2013 9:57:41 AM
More...
|
NicOx SA (COX.PA) Release: Pre-Clinical Results on Naproxcinod in Models of Muscular Dystrophy Presented at Muscular Dystrophy Association Scientific Conference
4/24/2013 10:23:45 AM
More...
|
NicOx SA (COX.PA) 2012 Financial Results and Business Update
3/22/2013 8:57:00 AM
More...
|
NicOx SA (COX.PA) to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/7/2013 9:29:08 AM
More...
|
Bausch & Lomb Initiates Phase 3 Program for Glaucoma Drug Candidate Licensed From NicOx SA (COX.PA)
1/29/2013 9:24:05 AM
More...
|
Dudnyk Wins Agency of Record Account for NicOx SA (COX.PA)
11/15/2012 11:30:05 AM
More...
|
NicOx SA (COX.PA) Attends 2012 American Academy of Ophthalmology Meeting in Chicago
11/9/2012 9:38:21 AM
More...
|
NicOx SA (COX.PA) Reports Financial Results for the Nine Months to September 2012
10/25/2012 8:58:21 AM
More...
|
NicOx SA (COX.PA) Launches AdenoPlus™ in the United States
10/22/2012 8:33:42 AM
More...
|
|